Ericson William W.

CIK 00015033816 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001503381

Recent Transactions

50 trades

Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2025-06-04+65,000→ 65,000 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2024-06-18+22,821→ 41,616 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2024-06-18+32,179→ 32,179 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2023-05-24+25,775→ 25,775 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2023-03-15−25,000→ 0 total
Sale
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2023-03-15$8.90/sh−7,541→ 18,795 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2023-03-15$2.54/sh+25,000→ 26,336 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2022-05-25+63,015→ 63,015 total
Other
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2022-03-17−4,848,397→ 0 total
Other
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2022-03-17+1,268→ 1,336 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−265,150→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−287,992→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−10,000→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−25,661→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−4,031,804→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−3,146→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−10,000→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−10,000→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−6,043→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−10,000→ 0 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2021-06-16+12,885→ 12,885 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-06-02+5,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-05-25$1.83/sh+25,000→ 37,500 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2021-05-25−12,500→ 0 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2021-05-25−25,000→ 0 total
Sale
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-05-25$26.42/sh−900→ 0 total
Exercise/Conversion
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-05-25$10.58/sh+12,500→ 12,500 total
Sale
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-05-25$25.88/sh−36,600→ 900 total
Other
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-02-12−750,000→ 4,848,397 total
Other
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2021-02-12+68→ 68 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2020-08-04+97,785→ 97,785 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2020-06-03+10,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2020-06-03+5,000→ 5,000 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+127,504→ 127,504 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+882→ 19,621 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+61,592→ 2,458,209 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+107,812→ 2,396,617 total
Conversion
Personalis, Inc.$PSNL
Series B Convertible Preferred Stock
2019-06-24−882→ 0 total
Conversion
Personalis, Inc.$PSNL
Series B Convertible Preferred Stock
2019-06-24−107,812→ 0 total
Conversion
Personalis, Inc.$PSNL
Series A Convertible Preferred Stock
2019-06-24−2,288,805→ 0 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+504→ 20,125 total
Conversion
Personalis, Inc.$PSNL
Series C Convertible Preferred Stock
2019-06-24−504→ 0 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+18,739→ 18,739 total
Conversion
Personalis, Inc.$PSNL
Series A Convertible Preferred Stock
2019-06-24−18,739→ 0 total
Conversion
Personalis, Inc.$PSNL
Series C Convertible Preferred Stock
2019-06-24−127,504→ 0 total
Conversion
Personalis, Inc.$PSNL
Common Stock
2019-06-24+2,288,805→ 2,288,805 total
Conversion
Personalis, Inc.$PSNL
Series C Convertible Preferred Stock
2019-06-24−61,592→ 0 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2019-06-05+10,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-06-06+10,000→ 10,000 total

Companies

Recent Filings

Address

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1380 WILLOW ROAD

MENLO PARK, CA, 94025

View on SEC.gov